Cargando…
Fulminant cerebral edema as a lethal manifestation of COVID-19
The contribution of neurological symptomatology to morbidity and mortality after infection with Severe Acute Respiratory Syndrome-associated Coronavirus (SARS CoV II) is ill-defined. We hereby present a case of a 57-year old male patient, in excellent physical condition, who was admitted to the Inte...
Autores principales: | van den Enden, Antoon J.M., van Gils, Lennart, Labout, Joost A.M., van der Jagt, Mathieu, Moudrous, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332918/ https://www.ncbi.nlm.nih.gov/pubmed/32733625 http://dx.doi.org/10.1016/j.radcr.2020.06.053 |
Ejemplares similares
-
The Minimum Percentage of Triolein Emulsion for Studying Cerebral Vascular Permeability with Least Brain Edema
por: Choi, Seon Hee, et al.
Publicado: (2014) -
Case report: Reversible restricted diffusion and cytotoxic edema in the perilesional zone following continuous partial seizures
por: Goyal, MK, et al.
Publicado: (2008) -
Lethal disseminated dysembryoplastic neuroepithelial tumor following West Nile virus: Report of a very unusual combination
por: Farkas, Amy, et al.
Publicado: (2018) -
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19
por: Al Mazrouei, Safaa Saeed, et al.
Publicado: (2020) -
Pseudoprogression of CNS metastatic disease of alveolar soft part sarcoma during anti-PDL1 treatment()()
por: Vander Jagt, Thomas A., et al.
Publicado: (2018)